Profilo
Greg DeFilippis worked as a Vice President-Business Development & Alliances at Antares Pharma, Inc. from 2013 to 2019.
Prior to that, he was a Director-Business Development at Teva Pharmaceuticals USA, Inc. Mr. DeFilippis holds an MBA degree from Fairleigh Dickinson University and an undergraduate degree from Virginia Polytechnic Institute & State University.
Precedenti posizioni note di Greg DeFilippis
Società | Posizione | Fine |
---|---|---|
ANTARES PHARMA, INC. | Corporate Officer/Principal | 01/12/2019 |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Formazione di Greg DeFilippis
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Borsa valori
- Insiders
- Greg DeFilippis